Meningococcal vaccine may reduce gonorrhoea incidence

Griffith Enterprise
A world-first trial for a promising gonorrhoea vaccine will be led by Griffith University’s Institute for Glycomics and the Kirby Institute at UNSW Sydney. The $2.7 million study incorporates five Australian universities and three health districts and providers, and will test whether a meningococcal B vaccine protects against gonorrhoea in gay and bisexual men. “Gonorrhoea […]

$1.2 million in funding for Griffith disease research

Griffith University research into fighting diseases of global impact are set to benefit from the latest National Health and Medical Research Council (NHMRC) 2018 Fellowship Program funding outcomes. Principal Research Leader Professor Suresh Mahalingam of the Institute for Glycomics has been successful in obtaining a Senior Research Fellowship B (SRFB) for the project “Arbovirus-Induced Inflammatory Disease: […]

Improved dressings urgently needed for intravenous catheter failures 

Griffith Health
New ways of improving the effectiveness of dressings and securements for the prevention of peripheral intravenous catheter (PIVC) failure in adults is urgently required. This is according to Professor Claire Rickard from the Alliance for Vascular Access Teaching and Research, a part of Griffith’s Menzies Health Institute Queensland, following new research published in The Lancet medical journal. PIVCs are […]